GALECTIN THERAPEUTICS INC (GALT) [Rocket]

Overview

GALECTIN THERAPEUTICS INC (GALT)

Add to portfolio

1m \| 3m \| 6m \| 1y \| 2y \| 5y \| 10y

Recent News + Filings (All items)

Date Filed	Type	Description
10/06/2023	ARS	Form ARS - Annual Report to Security Holders:
10/06/2023	DEFA14A	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
10/06/2023	DEF 14A	Form DEF 14A - Other definitive proxy statements:
10/02/2023	4	Form 4 - Statement of changes in beneficial ownership of securities:
09/27/2023	4	Uihlein Richard E (10% Owner) has filed a Form 4 on GALECTIN THERAPEUTICS INC
08/15/2023	4	LEWIS JOEL (President and CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC
08/14/2023	8-K	Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14
Revenues	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Cost of goods sold	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Gross profit	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Gross margin
Research and development	23.8	18.0	7.5	6.5	11.7	15.3	13.1	8.4
General and administrative	6.4	5.5	6.0	7.1	4.5	6.2	7.0	7.0
EBITA	-30.2	-23.4	-13.4	-13.6	-16.2	-21.5	-20.1	-15.8
EBITA margin
Amortization of intangibles					0.0	0.0	0.0	0.0
EBIT	-30.2	-23.4	-13.4	-13.6	-16.2	-21.5	-20.1	-15.8
EBIT margin
Pre-tax income	-30.5	-23.5	-13.3	-13.9	-16.2	-21.4	-20.0	-15.8
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-30.7	-23.6	-20.2	-15.0	-17.5	-22.4	-21.1	-17.0
Net margin

Diluted EPS	($0.52)	($0.41)	($0.39)	($0.38)	($0.49)	($0.76)	($0.88)	($0.78)
Shares outstanding (diluted)	58.5	57.0	52.2	39.4	35.5	29.2	24.1	21.8

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.